[1] |
Forner A, Reig M, Bruix J. Hepatocellular carcinoma[J]. Lancet,2018,391(10127): 1301-1314.
|
[2] |
Siegel R, Ma JM, Zou ZH,et al. Cancer statistics,2014[J]. CA Cancer J Clin,2014,64(1): 9-29.
|
[3] |
Bray F, Ferlay J, Soerjomataram I,et al. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries[J]. CA Cancer J Clin,2018,68(6): 394-424.
|
[4] |
Piñero F, Poniachik J, Ridruejo E,et al. Hepatocellular carcinoma in Latin America: diagnosis and treatment challenges[J]. World J Gastroenterol,2018,24(37): 4224-4229.
|
[5] |
Ng KKC, Cheung TT, Wong TCL,et al. Long-term survival comparison between primary transplant and upfront curative treatment with salvage transplant for early stage hepatocellular carcinoma[J]. Asian J Surg,2019,42(2): 433-442.
|
[6] |
Dimitroulis D, Damaskos C, Valsami S,et al. From diagnosis to treatment of hepatocellular carcinoma: An epidemic problem for both developed and developing world[J]. World J Gastroenterol,2017,23(29): 5282-5294.
|
[7] |
Medhat E, Abdel Aziz A, Nabeel M,et al. Value of microwave ablation in treatment of large lesions of hepatocellular carcinoma[J]. J Dig Dis,2015,16(8): 456-463.
|
[8] |
Han Y, Shao N, Xi XM,et al. Use of microwave ablation in the treatment of patients with multiple primary malignant tumors[J]. Thorac Cancer,2017,8(4): 365-371.
|
[9] |
Yu J, Liang P. Status and advancement of microwave ablation in China[J]. Int J Hyperthermia,2017,33(3):278-287.
|
[10] |
Littrup PJ, Aoun HD, Adam B,et al. Percutaneous cryoablation of hepatic tumors: long-term experience of a large US series[J]. Abdom Radiol(NY),2016,41(4): 767-780.
|
[11] |
Hu KQ. Advances in clinical application of cryoablation therapy for hepatocellular carcinoma and metastatic liver tumor[J]. J Clin Gastroenterol,2014,48(10): 830-836.
|
[12] |
Rong GH, Bai WL, Dong Z,et al. Long-term outcomes of percutaneous cryoablation for patients with hepatocellular carcinoma within Milan criteria[J]. PLoS One,2015,10(4): e0123065.
|
[13] |
Lo GH. Is cryoablation really more effective than radiofrequency ablation in hepatocellular carcinoma?[J]. Hepatology,2016,63(6):2061.
|
[14] |
Xu J, Noda C, Erickson A,et al. Radiofrequency ablation vs. cryoablation for localized hepatocellular carcinoma: A propensity-matched population study[J]. Anticancer Res,2018,38(11): 6381-6386.
|
[15] |
Liu CH, Yu CY, Chang WC,et al. Computed tomographic-guided percutaneous radiofrequency ablation with hydrodissection of hepatic malignancies in the subcapsular location: Evaluation of safety and technical efficacy[J]. J Chin Med Assoc,2016,79(2): 93-100.
|
[16] |
Cardella JF, Kundu S, Miller DL,et al. Society of interventional radiology clinical practice guidelines[J]. J Vasc Interv Radiol,2009,20(Suppl 7): S189-S191.
|
[17] |
Wang CP, Wang HM, Yang WW,et al. Multicenter randomized controlled trial of percutaneous cryoablation versus radiofrequency ablation in hepatocellular carcinoma[J]. Hepatology,2015,61(5): 1579-1590.
|
[18] |
Yu J, Yu XL, Han ZY,et al. Percutaneous cooled-probe microwave versus radiofrequency ablation in early-stage hepatocellular carcinoma: a phase III randomised controlled trial[J]. Gut,2017,66(6): 1172-1173.
|
[19] |
Filippiadis DK, Gkizas C, Chrysofos M,et al. Percutaneous microwave ablation of renal cell carcinoma using a high power microwave system: focus upon safety and efficacy[J]. Int J Hyperthermia,2018,34(7): 1077-1081.
|
[20] |
Gao YY, Wang Y, Duan YQ,et al. 915MHz microwave ablation with high output power in in vivo porcine spleens[J]. Eur J Radiol,2010,75(1): 87-90.
|
[21] |
Knavel EM, Hinshaw JL, Lubner MG,et al. High-powered gas-cooled microwave ablation: shaft cooling creates an effective stick function without altering the ablation zone[J]. AJR Am J Roentgenol,2012,198(3): W260-W265.
|
[22] |
Smolock AR, Lubner MG, Ziemlewicz TJ,et al. Microwave ablation of hepatic tumors abutting the diaphragm is safe and effective[J]. AJR Am J Roentgenol,2015,204(1): 197-203.
|
[23] |
Zhang H, Fan WJ, Huang ZL,et al. Computed tomography-guided percutaneous microwave ablation for diaphragm-abutting liver tumors: assessments of safety and short-term therapeutic efficacies[J]. Zhonghua Yi Xue Za Zhi,2014,94(17): 1313-1317.
|
[24] |
Zhang DD, Xie DL, Wei XL,et al. Microwave ablation of the liver abutting the stomach: insulating effect of a chitosan-based thermosensitive hydrogel[J]. Int J Hyperthermia,2014,30(2): 126-133.
|
[25] |
Filippiadis DK, Spiliopoulos S, Konstantos C,et al. Computed tomography-guided percutaneous microwave ablation of hepatocellular carcinoma in challenging locations: safety and efficacy of high-power microwave platforms[J]. Int J Hyperthermia,2018,34(6): 863-869.
|
[26] |
Hyun MH, Chung SM. Randomized,controlled trial of percutaneous cryoablation versus radiofrequency ablation in hepatocellular carcinoma[J]. Hepatology,2015,62(3): 980.
|
[27] |
Orlacchio A, Bazzocchi G, Pastorelli D,et al. Percutaneous cryoablation of small hepatocellular carcinoma with US guidance and CT monitoring: initial experience[J]. Cardiovasc Intervent Radiol,2008,31(3): 587-594.
|
[28] |
Hsieh YC, Limquiaco JL, Lin CC,et al. Radiofrequency ablation following artificial ascites and pleural effusion creation may improve outcomes for hepatocellular carcinoma in high-risk locations[J]. Abdom Radiol(NY),2019,44(3): 1141-1151.
|
[29] |
Kim GM, Won JY, Kim MD,et al. Cryoablation of hepatocellular carcinoma with high-risk for percutaneous ablation: safety and efficacy[J]. Cardiovasc Intervent Radiol,2016,39(10): 1447-1454.
|
[30] |
Wong SN, Lin CJ, Lin CC,et al. Combined percutaneous radiofrequency ablation and ethanol injection for hepatocellular carcinoma in high-risk locations[J]. AJR Am J Roentgenol,2008,190(3): W187-W195.
|